Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) Stock Price & Growth Analysis

Quote Panel

Updated September 9, 2025

1W -1.93 % 1M 0.07 % 3M -10.45 % 1Y -1.77 %

Key Metrics

Market Cap
95.64B
Shares Outstanding
121.74M
Share in Float
121.65M
Dividende
1.5

Earning Date
30 Oct 2025
Price Target
785.55
Average Volume
4
Beta
0.35759732

Range
735.5-1225
Industry
Drug Manufacturers - General
Website
http://www.bms.com
Sector
Healthcare

Quote Panel

Updated September 9, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

27.10x

P/E Ratio

1.99x

P/S Ratio

5.45x

P/B Ratio

2.9

Debt/Equity

10.6%

Net Margin

$0.2

EPS

How BMYMP compares to sector?

P/E Ratio

Fundamentals

Relative Strength

BMYMP

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

BMYMP

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$43B

254%

2026-Revenue

$6.02

841%

2026-EPS

$13B

286%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Buy

Price Target

N/A(N/A)

Number of analyst

N/A

Last analyst upgrade/downgrade

Credit Suisse

initialise

Previous: Not converted

2022-11-18

Now: Neutral

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q3.23

-5%

14.37
vs 15.07

Q4.23

-9%

13.33
vs 14.65

Q1.24

N/A

-90.58
vs 16.47

Q2.24

-16%

12.74
vs 15.17

Q3.24

-36%

9.17
vs 14.37

Q4.24

-96%

0.55
vs 13.33

Q1.25

+121%

18.63
vs -90.58

Q2.25

-95%

0.64
vs 12.74

Q3.25

-82%

1.69
vs 9.17

Q4.25

+189%

1.57
vs 0.55

Sales Growth

YoY

Current

Estimates

Q3.23

-2%

11B vs 11.2B

Q4.23

+1%

11.5B vs 11.4B

Q1.24

+5%

11.9B vs 11.3B

Q2.24

+9%

12.2B vs 11.2B

Q3.24

+8%

11.9B vs 11B

Q4.24

+8%

12.3B vs 11.5B

Q1.25

-6%

11.2B vs 11.9B

Q2.25

+1%

12.3B vs 12.2B

Q3.25

-1%

11.8B vs 11.9B

Q4.25

-3%

12B vs 12.3B

Return on Equity

QoQ

Q1.23

+7%

0.07
vs 0.07

Q2.23

+6%

0.06
vs 0.07

Q3.23

+7%

0.07
vs 0.06

Q4.23

+6%

0.06
vs 0.07

Q1.24

-72%

-0.72
vs 0.06

Q2.24

+10%

0.1
vs -0.72

Q3.24

+7%

0.07
vs 0.1

Q4.24

+0%

0
vs 0.07

Q1.25

+14%

0.14
vs 0

Q2.25

+8%

0.08
vs 0.14

Institutionnal Ownership

N/A

Q2.23

NA
vs NA

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Earnings Growth

YoY

Current

Estimates

Q3.23

-5%

14.37
vs 15.07

Q4.23

-9%

13.33
vs 14.65

Q1.24

N/A

-90.58
vs 16.47

Q2.24

-16%

12.74
vs 15.17

Q3.24

-36%

9.17
vs 14.37

Q4.24

-96%

0.55
vs 13.33

Q1.25

+121%

18.63
vs -90.58

Q2.25

-95%

0.64
vs 12.74

Q3.25

-82%

1.69
vs 9.17

Q4.25

+189%

1.57
vs 0.55

Sales Growth

YoY

Current

Estimates

Q3.23

-2%

11B vs 11.2B

Q4.23

+1%

11.5B vs 11.4B

Q1.24

+5%

11.9B vs 11.3B

Q2.24

+9%

12.2B vs 11.2B

Q3.24

+8%

11.9B vs 11B

Q4.24

+8%

12.3B vs 11.5B

Q1.25

-6%

11.2B vs 11.9B

Q2.25

+1%

12.3B vs 12.2B

Q3.25

-1%

11.8B vs 11.9B

Q4.25

-3%

12B vs 12.3B

Return on Equity

QoQ

Q1.23

+7%

0.07
vs 0.07

Q2.23

+6%

0.06
vs 0.07

Q3.23

+7%

0.07
vs 0.06

Q4.23

+6%

0.06
vs 0.07

Q1.24

-72%

-0.72
vs 0.06

Q2.24

+10%

0.1
vs -0.72

Q3.24

+7%

0.07
vs 0.1

Q4.24

+0%

0
vs 0.07

Q1.25

+14%

0.14
vs 0

Q2.25

+8%

0.08
vs 0.14

Institutionnal Ownership

N/A

Q2.23

NA
vs NA

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Company Description

785.55USD

27.10x

1.99x

5.45x

2.9

10.6%

$0.2

$43B

$6.02

$13B

Earnings Growth

Latest News

Latest News

Latest News

$43B

$6.02

$13B

Company Description

785.55USD

Earnings Growth

27.10x

1.99x

5.45x

2.9

10.6%

$0.2